CD263 (TRAIL-R3), Human Antibody from MILTENYI BIOTEC B.V. & Co. KG
Search, find, compare suppliers for anti-CD263 (TRAIL-R3), Human antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | CD263 (TRAIL-R3), Human |
| Clone | DJR3 |
| Host Species | Mouse |
| Reactive Species | human |
| Isotype | IgG1κ |
| Format | allophycocyanin (APC) conjugate |
| Size | 100 tests in 1 mL |
| Concentration | 1:11 |
| Applications | Flow cytometry |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | CD263 (TRAIL-R3) Antibody, anti-human, APC. Clone DJR3 recognizes the human CD263 antigen, a glycophospholipid-anchored cell membrane protein which is also known as TNF-related apoptosis-inducing ligand receptor 3 (TRAIL-R3) or tumor necrosis factor receptor superfamily member 10C (TNFRSF10C). CD263 is the receptor for the cytotoxic ligand TRAIL. It lacks a cytoplasmic death domain shared by several members of the TNF receptor superfamily and hence is not capable of inducing apoptosis. CD263 is highly expressed in peripheral blood lymphocytes, spleen, skeletal muscle, placenta, lung, and heart. It is higher expressed in normal tissues than in tumor cell lines. |
| Immunogen | n/a |
| Other Names | TNFRSF10C, DCR1, DCR1-TNFR, LIT, TRAIL-R3, TRAILR3, TRID |
| Gene, Accession # | Gene ID: 8794 |
| Catalog # | 130-104-742 |
| Price | $325 |
| Order / More Info | CD263 (TRAIL-R3), Human Antibody from MILTENYI BIOTEC B.V. & Co. KG |
| Product Specific References | Mongkolsapaya, J. et al. (1998) Lymphocyte inhibitor of TRAIL (TNF-related apoptosis-inducing ligand): a new receptor protecting lymphocytes from the death ligand TRAIL. J Immunol 160 (1): 3-6. | Degli-Esposti, M. A. et al. (1997) Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family. J. Exp. Med. 186 (7): 1165-1170. | Ursini-Siegel, J. et al. (2007) Elevated expression of DecR1 impairs ErbB2/Neu-induced mammary tumor development. Mol. Cell. Biol. 27 (18): 6361-6371. |
MILTENYI BIOTEC B.V. & Co. KG
MILTENYI BIOTEC B.V. & Co. KG
Friedrich-Ebert-StraÃe 68
51429 Bergisch Gladbach GERMANY
P: +49 2204 8306-0
F: +49 2204 85197
macs@miltenyibiotec.de
https://www.miltenyibiotec.com
Profile of MILTENYI BIOTEC B.V. & Co. KG
Return to Antibodies